Company / SG&A per Share
TScan Therapeutics, Inc. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.27
FY2025
5-year range
$0.27 / $7.36
FY2021-FY2025
Trend
-32.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 4 consecutive years, from $7.36 in FY2021 to $0.27 in FY2025.
Based on SEC 10-K filings.
0.27 in FY2025 with a 3-year CAGR of -38.9%.
Improved from $0.85 to $0.27 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -38.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TScan Therapeutics, Inc.'s sg&a per share has declined for 4 consecutive years.
- In FY2025, sg&a per share decreased 32.7% year-over-year.
- Peak sg&a per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -32.7% |
| FY2024 | $0.40 | -52.5% |
| FY2023 | $0.85 | -28.6% |
| FY2022 | $1.19 | -83.9% |
| FY2021 | $7.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026